Mayo, Illumina forge bioinformatics partnership for genetic disorder testing
Mayo Clinic and biotechnology firm Illumina will collaborate on next-generation sequencing technology to further Mayo’s genetic and genomic research, the orgnizations announced today.
Powered by WPeMatico
